Literature DB >> 11368405

Identification of Cripto-1 in human milk.

C Bianco1, C Wechselberger, A Ebert, N I Khan, Y Sun, D S Salomon.   

Abstract

Cripto-1 (CR-1) is an epidermal growth factor (EGF)-related peptide that plays an important role in normal mammary gland development. CR-1 is expressed in the growing terminal end buds in the virgin mouse mammary gland and its expression increases during pregnancy and lactation. Furthermore, CR-I is involved in the early stages of mouse mammary tumorigenesis and in the pathogenesis of human breast cancer. Since CR-1 is expressed in the mouse mammary gland at high levels during pregnancy and lactation, we have evaluated whether this protein is present in human milk. In the present study we demonstrate that a 28 kDa immunoreactive CR-1 protein is present in 24 human milk samples as assessed by western blot analysis and that by enzyme-linked immunosorbent assay the concentration of CR-1 ranges between 62 and 118 ng/ml. In addition, CR-1 that had been purified from human milk is able to stimulate the phosphorylation of mitogen activated protein kinase in nontransformed NMuMG mouse mammary epithelial cells. These results suggest that CR-1 in human milk may be important in regulating mammary gland development during pregnancy and lactation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368405     DOI: 10.1023/a:1010648923432

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland.

Authors:  Luigi Strizzi; Mario Mancino; Caterina Bianco; Ahmed Raafat; Monica Gonzales; Brian W Booth; Kazuhide Watanabe; Tadahiro Nagaoka; David L Mack; Beatrice Howard; Robert Callahan; Gilbert H Smith; David S Salomon
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

2.  Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.

Authors:  Youping Sun; Luigi Strizzi; Ahmed Raafat; Morihisa Hirota; Caterina Bianco; Lionel Feigenbaum; Nicholas Kenney; Christian Wechselberger; Robert Callahan; David S Salomon
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 3.  Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Authors:  Maria C Rangel; Hideaki Karasawa; Nadia P Castro; Tadahiro Nagaoka; David S Salomon; Caterina Bianco
Journal:  Am J Pathol       Date:  2012-04-26       Impact factor: 4.307

4.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

5.  Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression.

Authors:  Luigi Strizzi; Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Daniel E Abbott; Richard E B Seftor; David S Salomon; Mary J C Hendrix
Journal:  Breast Dis       Date:  2008

Review 6.  Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.

Authors:  Maria Cristina Rangel; Daniel Bertolette; Nadia P Castro; Malgorzata Klauzinska; Frank Cuttitta; David S Salomon
Journal:  Breast Cancer Res Treat       Date:  2016-03-11       Impact factor: 4.872

Review 7.  TGF-β superfamily co-receptors in cancer.

Authors:  John B Pawlak; Gerard C Blobe
Journal:  Dev Dyn       Date:  2021-04-09       Impact factor: 3.780

8.  Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.

Authors:  Md Jahangir Alam; Ryota Takahashi; Said M Afify; Aung Ko Ko Oo; Kazuki Kumon; Hend M Nawara; Aprilliana Cahya Khayrani; Juan Du; Maram H Zahra; Akimasa Seno; David S Salomon; Masaharu Seno
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.